The burden of RSV-associated hospitalization was high in older adults, with the greatest risk among the oldest age strata and those with CHF.

Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma,” "Connect” or the "Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of ...

Detailed price information for Connect Biopharma Holdings Ltd ADR (CNTB-Q) from The Globe and Mail including charting and trades.

Rademikibart achieved rapid, durable efficacy results across all key endpoints through 52 weeks, with near- maximal responses achieved in ~90% of patients - - Rademikibart was well tolerated with safe ...

Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.

Clinical benefits of the interleukin-33 inhibitor were observed in a broad population, including both former and current smokers, regardless of eosinophil levels. Topline results were announced from ...

Going from a medium-dose inhaled corticosteroid to a biologic for asthma led to significant decreases in exacerbations, ...

Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...

Rival treatments had mixed results in the past AstraZeneca sees $3-5 billion peak annual sales for its drug Detailed results to be presented at upcoming medical conference Shares among biggest gainers ...

Correspondence to Professor Martin Schwellnus, Sport, Exercise Medicine and Lifestyle Institute, University of Pretoria, Faculty of Health Sciences, Pretoria, South Africa; mschwell{at}iafrica.com ...

Background Shared decision making (SDM) is advocated as an approach for patient-centred asthma care. However, this approach ...